Slingshot members are tracking this event:
Agios Pharma (AGIO) data from Phase 1 trial of AG-120 underwhelms investors
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Nov 09, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 1 Data, Ag-120, Idh1 Inhibitor, Glioma, Sarcoma, Liver Tumor